Show simple item record

Polycystic Ovarian Syndrome: Evaluating the optimal therap

dc.contributor.authorEllafi, Abdelmuaz
dc.date.accessioned2020-09-26T11:40:44Z
dc.date.available2020-09-26T11:40:44Z
dc.date.issued2020-10-03
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/1998
dc.descriptionPolycystic Ovarian Syndrome, formerly called (Stein-Leventhal syndrome) is a heterogeneous and complex disorder that has adverse reproductive and metabolic implications for affected women. This disorder has an unclear etiology1. The most accurate and widely accepted clinical definition of PCOS is the association of hyperandrogenism with chronic anovulation in women without an underlying disease of pituitary or adrenal glands, along with the presence of polycystic ovaries. If two of these three criteria were present then the patient can be diagnosed with PCOS2. PCOS affects 5-10% of women of reproductive age. Hyperandrogenism is characterized clinically by hirsutism, acne, and androgen-dependent alopecia and biochemically by elevated serum concentrations of androgens, particularly testosterone and androstenedioneen_US
dc.description.abstractThis report reviews the treatment of Polycystic Ovarian Syndrome (PCOS) and early diagnosis helps in the effective treatment. Polycystic ovarian syndrome affects women's ovulation and also leads to infertility. Treatment-resistant acne and acanthosis nigricans are symptoms for this disorder. A number of cases have discussed this issue thoroughly and results concluded that dietary changes, metformin and clomiphene are all effective ways in the treatment of this disorderen_US
dc.language.isoenen_US
dc.publisherfaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titlePolycystic Ovarian Syndrome: Evaluating the optimal therapen_US
dc.typeOtheren_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States